These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 55397)

  • 41. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 42. Characterization of serum factors modulating splenic cytotoxicity in a syngeneic rat tumour system.
    Chalmers PJ; Matthews N; Nairn RC
    Br J Cancer; 1976 Dec; 34(6):645-50. PubMed ID: 1087566
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotype analyses and cellular mechanisms of the pre-effector T-lymphocyte response to a progressive syngeneic murine sarcoma.
    Sakai K; Chang AE; Shu SY
    Cancer Res; 1990 Jul; 50(14):4371-6. PubMed ID: 2114215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cross-reacting antigens in chemically induced sarcomas are fetal determinants.
    Parker GA; Rosenberg SA
    J Immunol; 1977 May; 118(5):1590-4. PubMed ID: 67142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Serological aspects of rat tumour xenograft growth in athymic nude mice.
    Pimm MV; Baldwin RW
    Br J Cancer; 1979 Feb; 39(2):116-21. PubMed ID: 373782
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene.
    Bloom ET
    J Natl Cancer Inst; 1970 Sep; 45(3):443-53. PubMed ID: 5523193
    [No Abstract]   [Full Text] [Related]  

  • 47. Relationship of tumor-specific transplantation antigens to the histocompatibility complex: dissociation of in vitro alloantigen expression and in vivo alloimmunity from tumor-specific transplantation antigen strength.
    Chauvenet PH; Smith RT
    Int J Cancer; 1978 Jul; 22(1):79-90. PubMed ID: 79560
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transplantation immunity of rats induced by hepatoma cells treated with heteroantibody.
    El-Asfahani AM; Maruta H; Mizuno D; Ishidate M; Hashimoto Y; Nishioka K
    Gan; 1975 Feb; 66(1):1-9. PubMed ID: 169181
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Impact of Ig-anti-Ig column fractionation on T-lymphocyte functions.
    Rubin B; Jorgensen PN; Guttler F; Hoier-Madsen M
    Scand J Immunol; 1976; 5(4):345-59. PubMed ID: 59945
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Soluble tumour-specific antigen and its relationship to tumour growth.
    Thomson DM
    Int J Cancer; 1975 Jun; 15(6):1016-29. PubMed ID: 50290
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surface membrane changes of T cells induced by syngeneic tumour cells. II. T-cell defects induced by small tumour cell inocula or tumour cell antigens.
    Chow DA; Paraskevas F; Dular U
    Int J Cancer; 1978 Nov; 22(5):621-9. PubMed ID: 309866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on chemically induced rat tumors. II. Partial protection against syngeneic lethal tumors by cloned syngeneic cytotoxic T lymphocytes.
    Binz H; Fenner M; Engel R; Wigzell H
    Int J Cancer; 1983 Oct; 32(4):491-500. PubMed ID: 6413434
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Radioimmunoassay of tumour specific transplantation antigen of a chemically induced rat sarcoma: circulating soluble tumour antigen in tumour bearers.
    Thomson DM; Sellens V; Eccles S; Alexander P
    Br J Cancer; 1973 Nov; 28(5):377-88. PubMed ID: 4758368
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Specific anti-tumor responses of cultured immune spleen cells III. Further characterization of cells which synthesize factors with blocking and antiserum-dependent cellular cytotoxic (ADC) activities.
    Nelson K; Pollack SB; Hellström KE
    Int J Cancer; 1975 Oct; 16(4):539-49. PubMed ID: 1080750
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of anti-tumor immunoglobulins and their daunomycin conjugates to the tumor and its metastase. In vitro and in vivo studies with Lewis lung carcinoma.
    Hurwitz E; Schechter B; Arnon R; Sela M
    Int J Cancer; 1979 Oct; 24(4):461-70. PubMed ID: 393637
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo expression of original and foreign H-2 antigens and of the tumor-associated transplantation antigen of a murine fibrosarcoma.
    Carbone G; Invernizzi G; Meschini A; Parmiani G
    Int J Cancer; 1978 Jan; 21(1):85-93. PubMed ID: 624601
    [No Abstract]   [Full Text] [Related]  

  • 58. Studies of humoral and cell-mediated immunity in human melanoma.
    Mukherji B; Nathanson L; Clark DA
    Yale J Biol Med; 1973 Dec; 46(5):681-92. PubMed ID: 4130586
    [No Abstract]   [Full Text] [Related]  

  • 59. Change of antigenic expression on rat tumor cells after their transplantation.
    Gotohda E; Sendo F; Nakayama M; Hosokawa M; Kawamura T
    J Natl Cancer Inst; 1975 Nov; 55(5):1079-83. PubMed ID: 1206734
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antigenic similarity between simian virus 40-induced surface and fetal antigens in hamster.
    Kato K
    J Natl Cancer Inst; 1977 Feb; 58(2):259-62. PubMed ID: 64617
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.